Overview

Effect of V0251 in Acute Vertigo

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Assessment of efficacy and tolerance of a new anti-dizziness drug in acute vertigo.
Phase:
Phase 2
Details
Lead Sponsor:
Pierre Fabre Medicament